Eliana MC Tacconi
Medtronic (Italy)(IT)
Publications by Year
Research Areas
DNA Repair Mechanisms, CRISPR and Genetic Engineering, Cancer Genomics and Diagnostics, Genomics and Phylogenetic Studies, Hepatocellular Carcinoma Treatment and Prognosis
Most-Cited Works
- → COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study(2020)599 cited
- → Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting Compounds(2015)257 cited
- → A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics(2014)241 cited
- → BRCA 1 and BRCA 2 tumor suppressors protect against endogenous acetaldehyde toxicity(2017)69 cited
- → Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinoma(2019)42 cited
- → Chlorambucil targets BRCA 1/2‐deficient tumours and counteracts PARP inhibitor resistance(2019)36 cited
- → <p>Review of Adjuvant Therapies in Renal Cell Carcinoma: Evidence to Date</p>(2020)30 cited
- → The economic burden of cancer, coronary heart disease, dementia, and stroke in England in 2018, with projection to 2050: an evaluation of two cohort studies(2024)27 cited
- → How homologous recombination maintains telomere integrity(2014)16 cited
- → A transcription-based mechanism for oncogenic β-catenin-induced lethality in BRCA1/2-deficient cells(2021)11 cited